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Abstract
Mycoplasma are a frequent and occult contaminant of cell cultures, whereby these prokary-
otic organisms can modify many aspects of cell physiology, rendering experiments that are
conducted with such contaminated cells problematic. ChronicMycoplasma contamination
in human monocytic cells lines has been associated with suppressed Toll-like receptor
(TLR) function. In contrast, we show here that components derived from aMycoplasma
hyorhinis-infected cell line can activate innate immunity in non-infected primary immune
cells. Release of pro-inflammatory cytokines such as IL-6 by dendritic cells in response to
Mycoplasma hyorhinis-infected cell components was critically dependent on the adapter
protein MyD88 but only partially on TLR2. Unlike canonical TLR2 signaling that is triggered
in response to the detection ofMycoplasma infection, innate immune activation by compo-
nents ofMycoplasma-infected cells was inhibited by chloroquine treatment and sensitive to
protease treatment. We further show that in plasmacytoid dendritic cells, soluble factors
fromMycoplasma hyorhinis-infected cells induce the production of large amounts of IFN-α.
We conclude thatMycoplasma hyorhinis-infected cell lines release protein factors that can
potently activate co-cultured innate immune cells via a previously unrecognized mecha-
nism, thus limiting the validity of such co-culture experiments.
Introduction
Mycoplasma are a heterogeneous group of wall-less, self-replicating prokaryotes with great
diversity in replication rates and culture requirements. Some species, such asMycoplasma
hyorhinis, are found as a frequent and occult contaminant of both human and murine cell cul-
tures. These organisms can modify many aspects of cell physiology, rendering the interpreta-
tion of experiments that are conducted with contaminated cells problematic [1]. Because of
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their slow growth and resistance against many antibiotics,Mycoplasma contamination of cell
cultures can progress undiscovered over a long period of time and thus represents a significant
problem in experimental research [2].
For the detection of pathogens, cells of the innate immune system are equipped with special-
ized pattern-recognition receptors (PRRs). These are germline-encoded receptors, which detect
conserved molecular structures that are specific to invading microbes but are not present in
uninfected host cells. Recognition of such pathogen-associated molecular patterns (PAMPs)
leads to activation and maturation of antigen-presenting cells, release of pro-inflammatory
cytokines and the initiation of a subsequent adaptive immune response. Toll-like receptors
(TLRs) constitute a family of trans-membrane PRRs that are broadly expressed in non-
hematopoietic and hematopoietic cells such as dendritic cells (DCs) [3]. TLR ligation by a vari-
ety of microbial components including lipopolysaccharides (LPS, TLR4) or DNA-containing
CpG motifs (TLR9) leads to activation of antigen-presenting cells, production of pro-inflam-
matory cytokines and the release of type I interferon (IFN-α and IFN-β) [4]. Downstream sig-
naling of TLRs is mediated by the adaptor proteins MyD88 (all TLRs except TLR3) and TRIF
(TLR3 and 4) [5]. Some TLRs such as TLR2 are localized on the cell surface and predominately
recognize microbial membrane components, whereas other TLRs such as TLR9 are expressed
within endosomes and mainly detect nucleic acids [3].
Mycoplasma-derived lipoproteins can be detected by both the human and murine innate
immune system through ligation to the outer plasma membrane-bound TLR2 and subsequent
downstream signaling via MyD88 [6]. Studies in primary murine macrophages [7] as well as
human embryonic kidney cell lines [8] have shown that heterodimerization with either TLR1
or TLR6 can augment TLR2 activity and allows for the discrimination of different lipoproteins.
Ligation ofMycoplasma-derived lipoproteins by TLR2 on murine DCs can result in potent
cytokine release and activation of bystander cells [9]. In mice, bone marrow-derived DCs that
genetically lack functional TLR2 showed abolished IL-6 production in response toMycoplasma
pulmonis [10], which translated into reduced resistance of TLR2-deficient mice against pulmo-
nary infection with liveM. pulmonis.
A previous report has shown that chronicMycoplasma contamination of the human mono-
cytic cell line THP-1 can suppress its responsiveness to various TLR stimuli [11]. Such immor-
talized cells and other tumor cell lines are commonly used to investigate their interaction with
immune cells. Primary immune cells of both murine and human origin are often used in co-
culture experiments together with cell lines and could thus be affected byMycoplasma without
being directly infected. Indeed, immune cells are poised to sense infection in surrounding cells
and to react rapidly to such a threat. In this study, we investigated whetherMycoplasma-
infected cell lines can affect primary bystander cells. We demonstrate that one or more protein-
ase-sensitive components derived fromMycoplasma hyorhinis-infected cell lines can activate
bystander, non-infected innate immune cells to produce pro-inflammatory cytokines indepen-
dently of canonical TLR2 signaling as well as type-I interferon by pDC, which both can
strongly corrupt results obtained by co-culturing experiments.
Materials and Methods
Ethics statement
This study was carried out in strict accordance to the guidelines of the German animal protec-
tion law (TierSchG). All procedures including housing and sacrifice were performed as autho-
rized by and were reported to the responsible state office Regierung von Oberbayern (ROB,
Germany) per standard legal procedure. Under this law, no special permit was necessary for
isolating organs from mice after they have been sacrificed by cervical dislocation following
Bystander Immune Activation byMycoplasma Contamination
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isoflurane anesthesia. No manipulations were performed and no samples were collected prior
to euthanasia.
Mice
Female C57BL/6 mice were purchased from Harlan-Winkelmann and Janvier. TLR2-deficient
mice (TLR2-/-) were a generous gift from Dirk H. Busch (Munich) and have been described
previously [12]. All mice were at least 8 weeks of age at the time of bone marrow harvest.
Cell lines
The murine B16-F10 (B16) melanoma cell line, CT26 colon carcinoma cell line and EL4 lym-
phoma cell line are commercially available (ATCC, Wesel, Germany) and have been described
previously [13–15]. Tumor cell lines were cultured in DMEM supplemented with 10% FCS, 2
mM L-glutamine and 100 μg/ml streptomycin and 1 IU/ml penicillin. The contaminating
Mycoplasma species was identified by commercial PCR multiplex testing (Multiplexion, Hei-
delberg, Germany) as described previously [16]. For the eradication ofMycoplasma, B16 cells
were cultured in the presence of 25 μg/ml Plasmocin (Invivogen, Toulouse, France) for 14
days. Cells were split every 2–3 days. Culture supernatants from passages 5–15 were centri-
fuged (400 G, 8 min) and were subsequently used for stimulation experiments. The culture
supernatant was mixed with fresh complete RPMI medium (10% FCS, 2 mM L-glutamine,
100 μg/ml streptomycin and 1 IU/ml penicillin) at a 1:1 ratio if not stated otherwise. Fresh
complete DMEMmedium mixed with RPMI at a similar ratio was used as negative control. In
some experiments the culture supernatant was filtered through a 0.22 μm filter (Merck Milli-
pore, Billerica, MA) and/or treated with UV irradiation (254 nm, 40.000 μJ/cm2; CL-1000
cross-linker from UVP, Upland, CA). To obtain lysates, cells were snap-frozen in liquid nitro-
gen at a density of approximately 1-2x107 cells/ml and thawed on ice prior to stimulation.
Generation of bone marrow-derived dendritic cells
Bone marrow cells were harvested from murine femur and tibia and erythrocytes were lysed
with ammonium chloride buffer (BD Biosciences, Heidelberg, Germany). For bone marrow-
derived GM-CSF DCs, mouse bone marrow cells were cultured in complete RPMI 1640 (10%
FCS, 2 mM L-glutamine, 100 μg/ml streptomycin and 1 IU/ml penicillin) supplemented with
20 ng/ml GM-CSF and 20 ng/ml IL-4 (Tebu Bio, Offenbach, Germany). On day 6 to 7, cells
were harvested. Plasmacytoid DC (pDC)-containing Flt3-DC were generated from bone mar-
row cells cultured in complete RPMI 1640 supplemented with 1 mM sodium pyruvate, 1%
non-essential amino acids (MEM-NEAA), 3.75 x 10−4% 2-mercaptoethanol and 20 ng/ml
recombinant Flt3-L (Peprotech, London, UK or Tebu Bio, Offenbach, Germany). On day 7 to
9, cells were harvested and B220+ pDCs were isolated with magnetic microbeads (Miltenyi Bio-
tec, Bergisch-Gladbach, Germany or BD iMAG, BD Biosciences, Heidelberg, Germany)
according to the manufacturer’s protocol.
Cell culture, stimulation and inhibitors
Murine immune cells were cultured in complete RPMI. LPS (5 μg/ml), FSL-1 (500 ng/ml) was
purchased from Invivogen. MALP-2 (500 ng/ml) was from Novus Biologicals (Cambridge,
UK). The PTO-modified CpG oligonucleotide 1826 (CpG, 3 μg/ml, 5’-TCCATGACGTTCCT-
GACGTT-3’) was synthesized by Eurofins MWG Operon (Ebersberg, Germany). The inhibitor
of endosomal TLR activity chloroquine (from Invivogen) was used at a concentration of 5 μM,
if not indicated otherwise. For stimulation of primary cells, supernatant from infected cells was
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mixed at a ratio of 1:1 with fresh medium. Cell lysates were mixed to responder cells at a ratio
of 1:100 if not stated otherwise. For protein digestion, cell lysates were treated with 16 U/ml
proteinase K (Sigma-Aldrich, Munich, Germany) at 55°C for 1 h with constant shaking. Enzy-
matic digestion of nucleid acids with RNase A and DNase I (both from Sigma-Aldrich) was
performed according to the manufacturer’s protocol.
Quantification of cytokines
The concentration of IL-1β, IL-6, IL-10 and IL-12p70 in the culture supernatant was deter-
mined by enzyme-linked immunosorbent assay (ELISA) according to the manufacturers’
instructions (BD Biosciences and BioLegend, San Diego, CA, USA). IFN-α was measured as
described previously [17]. In brief, rat monoclonal antibody to mouse IFN-α (clone RMMA-1)
was used as the capture antibody, rabbit polyclonal antibody to mouse IFN-α for detection
(both from PBL Biomedical Laboratories, Piscataway, NJ) together with HRP-conjugated don-
key antibody to rabbit IgG as the secondary reagent (Jackson ImmunoLaboratories, Bar Har-
bor, ME). Recombinant mouse IFN-α (PBL Biomedical Laboratories) was used as standard
(IFN-α concentration in IU/ml).
Quantitative real-time PCR
Total RNA was isolated from bone marrow cells lysed with TRIzol reagent (Ambion, Waltham,
MA) and was subsequently transcribed with the SuperScript III Reverse Transcriptase (Thermo
Fischer Scientific, Waltham, MA) according to the manufacturers’ protocol. The specific
primer pairs were as follows: mIL-6 fwd GTAGCTATGGTACTCCAGAAGAC, rev ACGA
TGATGCACTTGCAGAA; mActin fwd CACACCCGCCACCAGTTCG, rev CACCATCACA
CCCTGGTGC. The qPCR Core kit for SYBR Green I (Eurogentec, Köln, Germany) and a
LightCycler 480 II (Roche, Mannheim, Germany) real-Time PCR system were used for the
analysis.
Statistics
All data are presented as mean + S.E.M. Statistical significance of single experimental findings
was assessed with the independent two-tailed Student’s t-test. For multiple statistical compari-
son of a data set, the one-way ANOVA test with Bonferroni post-test was used. Significance
was set at p-values p< 0.05, p< 0.01 and p< 0.001 and was then indicated with an asterisk
(,  and ). All statistical calculations were performed using Graphpad Prism (GraphPad
Software, San Diego, USA).
Results
Mycoplasma-infected B16 cells stimulate production of pro-inflammatory
cytokines in primary immune cells
To investigate whetherMycoplasma-infected cell lines can affect bystander cells, freshly iso-
lated murine bone marrow cells, which harbor an abundance of different precursor and mature
immune cells, were cultured in the presence of supernatants or cell lysates fromMycoplasma
hyorhinis-infected B16-F10 murine melanoma cells (B16). Bone marrow cells that were supple-
mented with the supernatant from contaminated B16 cell cultures produced large amounts of
the pro-inflammatory cytokine IL-6 (Fig 1A). This effect was not restricted to the B16 mela-
noma line, since culture supernatant or cell lysates fromMycoplasma-contaminated CT26
colon carcinoma cells or the EL4 lymphoma cell line also resulted in potent IL-6 release from
co-cultured bone marrow cells (S1 Fig). Culture supernatant from B16 cells in which
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Mycoplasma had been eradicated by treatment with the antibiotic Plasmocin induced only
trace cytokine release, which was comparable to the background level induced by supernatant
from uninfected B16 cells. Activation of bone marrow cells was induced not only by culture
supernatant but also by cell lysates of infected B16 cells (Fig 1B). The well-characterized TLR
Fig 1. Mycoplasma hyorhinis-infected B16melanoma cells stimulate production of proinflammatory cytokines by primary immune cells. Freshly
isolated murine bone marrow cells were cultured in the presence of (A) the diluted cell culture supernatant (black bars) or (B) cell lysates (grey bars) of either
aMycoplasma hyorhinis-infected or non-infected B16 melanoma cell line. After 18 h, levels of IL-6 in the bone marrow cell culture supernatant were analyzed
by ELISA. The TLR4 ligand LPS and the TLR9 ligand CpG were used as positive controls. In one condition, supernatant from formerly infected B16 cells in
whichMycoplasma hyorhinis had been eradicated with the antibiotic Plasmocin, was used. (C) Bone marrow cells were cultured as in (B) in the presence of
either culture supernatant or cell lysates ofMycoplasma hyorhinis-infected B16 cells. The levels of IL-10, IL-12p70 and IL-1β were analyzed in the bone
marrow cell culture supernatant by ELISA after 18 h. All data give the mean + S.E.M. of triplicate samples and are representative of at least three
independent experiments. Asterisks indicate statistically significant differences to the non-stimulated control. ns, not significant; SN, supernatant.
doi:10.1371/journal.pone.0142523.g001
Bystander Immune Activation byMycoplasma Contamination
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ligands LPS and CpG were used as positive controls.Mycoplasma hyorhinis-infected B16 cells
also induced production of IL-10 and IL-12p70 but not IL-1β in co-cultured bone marrow cells
(Fig 1C). The infected B16 cells did not release any of these cytokines themselves (data not
shown). In conclusion,Mycoplasma hyorhinis-infected cell lines harbor and release a factor
that can stimulate bystander immune cells to produce pro-inflammatory cytokines.
Innate immune activation by aMycoplasma-infected cell line is
dependent on MyD88 signaling
As the detection of common pathogen-associated molecular patterns includingMycoplasma-
derived lipoproteins is largely dependent on TLRs and subsequent downstream signaling via
MyD88 and TRIF [3], we examined whether these two adapter proteins were critical for the
detection of the active components released from aMycoplasma hyorhinis-infected cell line by
innate immune cells in our setting. In addition to primary bone marrow cells, we analyzed
cytokine production by dendritic cells (DCs), which form a specialized subset of antigen-pre-
senting cells and are potent producers of pro-inflammatory cytokines in response to various
microbial stimuli. Both wild-type bone marrow cells and differentiated DCs (GM-CSF DCs)
produced IL-6 in response to culture supernatant ofMycoplasma hyorhinis-infected B16 cells
(Fig 2A and 2B). The release of IL-6 was greatly reduced in bone marrow cells and DCs from
MyD88-deficient mice. In contrast, deficiency for the TLR3/4 adapter protein TRIF did not
inhibit but rather enhanced cytokine secretion in response toMycoplasma hyorhinis-infected
cell culture material. Indeed, TRIF has been described as a negative regulator of MyD88-depen-
dent TLR signaling, as cytokine release downstream of MyD88 is strongly increased in TRIF-
deficient mice [18, 19].
As MyD88 is a central adapter protein to TLRs with both endosomal and cell surface locali-
zation, we next investigated in which cellular compartmentMycoplasma-infected cell compo-
nents are recognized. Bone marrow cells were treated with chloroquine, which is commonly
used as an inhibitor of endosomal TLRs [20, 21]. Treatment with chloroquine largely inhibited
the release of IL-6 by bone marrow cells in response toMycoplasma hyorhinis-infected cell line
components or the TLR9 ligand CpG (S2A Fig)In contrast, chloroquine did not block IL-6
production by bone marrow cells or GM-CSF DCs following stimulation with either the syn-
thetic lipoprotein TLR2 ligand FSL-1 or LPS (S2B and S2C Fig), which both activate surface-
localized TLRs.
MyD88 does not only mediate the downstream signaling of most TLRs but also of the IL-1
receptor family, whose members are commonly activated by caspase-1-dependent cleavage [3].
Treatment of bone marrow cells with the pan-caspase inhibitor zVAD did not influence IL-6
release in response to culture supernatant ofMycoplasma hyorhinis-infected B16 cells (data not
shown) indicating that immune cell activation was independent of bio-active IL-1 family mem-
bers. Taken together, these data show that sensing of components fromMycoplasma hyorhinis-
contaminated cell lines is mediated by MyD88 and is sensitive to the endosomal TLR inhibitor
chloroquine.
Immunostimulation byMycoplasma hyorhinis-infected B16 cells occurs
in the absence of active infection and is only partially dependent on
TLR2 signaling
As the detection of knownMycoplasma-derived lipoproteins is largely dependent on heterodi-
merization of TLR2 with either TLR1 or TLR6 and subsequent downstream signaling via
MyD88 [6, 7, 22], we examined whether TLR2 was critical for the detection of the active com-
ponents released from aMycoplasma-infected cell line in our setting. In GM-CSF DCs that
Bystander Immune Activation byMycoplasma Contamination
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Fig 2. Innate immune activation byMycoplasma hyorhinis-infected B16 cells is fully dependent on MyD88 signaling but only partially on TLR2. (A)
Bone marrow cells or (B) differentiated GM-CSF DCs from wild-type, MyD88- or TRIF-deficient mice were cultured in the presence of diluted supernatant
fromMycoplasma hyorhinis-infected B16 cells for 18 h. IL-6 levels in the immune cell culture supernatant were analyzed by ELISA. (C)GM-CSF DCs from
wild-type and TLR2-deficient mice were cultured as in (A) in the presence of diluted supernatant fromMycoplasma hyorhinis-infected B16 cells and IL-6
levels in the DC culture supernatant were analyzed by ELISA. (D)GM-CSF DCs from wild-type mice were cultured as in (A). In some conditions, the diluted
Bystander Immune Activation byMycoplasma Contamination
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genetically lack TLR2, the induction of IL-6 in response to culture supernatant fromMyco-
plasma hyorhinis-infected B16 cells was only reduced by 50% (Fig 2C). In sharp contrast, IL-6
stimulation with MALP-2 and other defined TLR2 agonists was completely abrogated in
absence of functional TLR2 signaling. These data demonstrate that the culture supernatant
fromMycoplasma hyorhinis-infected B16 cells contains both TLR2-dependent and TLR2-inde-
pendent immunostimulatory factors that activate bystander immune cells via the MyD88
pathway.
We next determined whether the immunostimulatory capacity of culture supernatant from
Mycoplasma hyorhinis-infected B 16 cells required active infection of target immune cells. Gen-
erally, when non-infected B16 cells were transiently cultured in the presence of supernatant
fromMycoplasma hyorhinis-contaminated cell lines, they were subsequently infected and
acquired the ability to induce production of IL-6 in primary immune cells (S3 Fig). To examine
whether infection of the DC culture by the contaminatingMycoplasma species was necessary
for immune activation, the supernatant fromMycoplasma hyorhinis-infected B16 cells was
treated by UV irradiation and/or filtration. Such decontaminated B16 culture supernatants
were no longer infectious (S3 Fig), but still induced strong IL-6 release in GM-CSF DCs (Fig
2D). These data show that the immune response in DCs to culture supernatant fromMyco-
plasma hyorhinis-contaminated cell lines is not dependent on active infection.
Innate immune activation byMycoplasma hyorhinis-infected B16 cells is
mediated by a protein factor
Endosomal TLRs are considered to detect mainly bacterial and viral nucleic acids. The ligation
ofMycoplasma-derived lipoproteins to TLR2 and its heterodimers with either TLR1 or TLR6
has been shown to be critically dependent on the ligand’s lipid moiety since digestion with
lipases but not proteases impaired the lipoproteins’ immunostimulatory capacity in human
monocytic cells [23]. To determine the nature of the component responsible for immune cell
activation byMycoplasma hyorhinis-infected cells, B16 cell lysates were treated either with
DNase I, RNase A or proteinase K before they were added to a bone marrow cell culture. Diges-
tion of nucleic acids within the B16 lysates did not decrease the capacity of infected cells to
induce IL-6 release from immune cells (Fig 3). In contrast, protein digestion with proteinase K
at 55°C resulted in strong inhibition of immunostimulation byMycoplasma-contaminated cell
lysates. Proteinase-treated B16 lysates failed to induce IL-6 production in bone marrow cells as
determined by ELISA from the culture supernatant (Fig 3). To rule out that a spillover of
enzyme to the bone marrow cell culture was responsible for the decrease in IL-6 protein, LPS-
stimulated bone marrow cells were additionally supplemented with proteinase K-treated mock
supernatants, which did not result in a decrease of IL-6 secretion. To further substantiate that
the ligand itself is degraded by protease treatment, IL-6 mRNA expression was determined by
quantitative real-time PCR. We found that proteinase K treatment of contaminated B16 cell
lysates resulted in strongly impaired upregulation of IL-6 mRNA levels in bone marrow cells
(S4 Fig) in contrast to LPS (not shown). In the absence of proteinase K, heating to 55°C
resulted in less pronounced reduction in immunostimulatory capacity ofMycoplasma-infected
cells. In conclusion, these data demonstrate thatMycoplasma hyorhinis-infected cell lines har-
bor a factor for which the pro-inflammatory activity is dependent on a protein component.
B16 culture supernatant was decontaminated by filtration (red bars), UV irradiation (blue bars) or both (purple bars) before it was added to the DC culture. IL-
6 levels in the DC culture supernatant were analyzed by ELISA after 18 h. Data give the mean + S.E.M. of triplicate samples and are representative of at least
two independent experiments. Asterisks indicate statistically significant differences to the appropriate wild-type control (in A-C) or to the appropriate non-
decontaminated conditions (in D).
doi:10.1371/journal.pone.0142523.g002
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Plasmacytoid dendritic cells produce IFN-α and IL-6 in response to
lysates ofMycoplasma hyorhinis-infected B16 cells
Dendritic cells can be divided into several subpopulations. In contrast to conventional DCs
(cDCs), that represent the main population in GM-CSF DC cultures, plasmacytoid DCs (pDC)
morphologically resemble plasma cells and their function strongly depends on endosomal
pathogen recognition via TLR7 and TLR9 [24]. To elucidate the role of pDCs in innate
immune activation by components ofMycoplasma-infected cell lines, we analyzed the triggered
cytokine release from bone marrow-derived pDCs. Following incubation with cell lysates from
Mycoplasma hyorhinis-infected B16 cells, pDCs showed production of IL-6 that was entirely
blocked by chloroquine treatment (Fig 4A). In contrast, pDCs did not respond to stimulation
with the synthetic lipoprotein TLR2 ligand FSL-1 (Fig 4B). These data suggest that the immu-
nostimulatory component fromMycoplasma hyorhinis-infected cells is recognized by pDCs
Fig 3. Innate immune activation byMycoplasma hyorhinis-infected B16 cells is mediated by a protein
factor. Bone marrow cells were cultured in the presence of cell lysates ofMycoplasma hyorhinis-infected B16
cells. Some cell lysates were pre-treated either with DNase, RNase or proteinase K. 18 h later, IL-6 levels in
the bone marrow cell culture supernatant were analyzed by ELISA. Protein digestion was performed at 55°C.
In one condition, B16 cell lysates were heated to 55°C in the absence of proteinase K. Data give the mean
values of triplicate samples + S.E.M. and are representative of two independent experiments. Asterisks
indicate statistically significant difference to the appropriate non-inhibitor-treated conditions. ND, not
determined.
doi:10.1371/journal.pone.0142523.g003
Bystander Immune Activation byMycoplasma Contamination
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within their endosomal compartment and is, as with cDC, distinct from canonical TLR2-de-
pendentMycoplasma-associated pathogenic patterns.
Functionally, pDCs are characterized by their ability to produce large amounts of type I
interferons (IFNs) upon different stimuli such as viral or bacterial nucleic acids [24]. Culture
supernatant fromMycoplasma hyorhinis-infected B16 cells induced concentration-dependent
production of IFN-α in pDCs that was abolished following chloroquine treatment (Fig 4C).
The synthetic lipoprotein TLR2 ligand FSL-1 did not induce IFN-α release by pDCs (Fig 4D).
In summary, pDCs release both pro-inflammatory cytokines and type-I IFN in response to
Mycoplasma hyorhinis-contaminated cell lines but not to canonical TLR2 PAMPs.
Discussion
We show here thatMycoplasma hyorhinis contamination in tumor cell lines can substantially
activate co-cultured bystander immune cells through a factor activating the MyD88 pathway.
Further, we have discovered a previously unknown crosstalk ofMycoplasma hyorhinis-infected
cells with pDCs leading to the secretion of IFN-α. Many insightful in vitro studies have been
Fig 4. Plasmacytoid dendritic cells produce IFN-α and IL-6 in response toMycoplasma hyorhinis-infected B16 cells. Bone marrow-derived
plasmacytoid DCs were cultured in the presence of decreasing concentrations of lysates derived fromMycoplasma hyorhinis-infected B16 cells (A, C) or
different TLR stimuli (B, D). In some conditions, chloroquine was added to the pDC cultures. After 18 h, IL-6 and IFN-α levels in the pDC culture supernatant
were analyzed by ELISA. Data give the mean + S.E.M. of triplicate samples and are representative of at least two independent experiments. Asterisks
indicate statistically significant differences to the appropriate wild-type or untreated conditions.
doi:10.1371/journal.pone.0142523.g004
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conducted to analyze the interaction of tumor cells with their immune cell microenvironment
[25, 26]. Because of the important regulatory potential of type I interferons and other induced
cytokines, we demonstrate that it is crucial to excludeMycoplasma contamination in this type
of study, even when the analyzed immune responder cells are not directly infected. It is note-
worthy that even short-term co-culture experiments of less than one day can be perturbed by
this crosstalk.
We have investigated the nature of this bystander immune cell activation and demonstrate
that the soluble pro-inflammatory factor released from aMycoplasma hyorhinis-infected B16
cell line can be inactivated by protease treatment. In addition, its detection by innate immune
cells was blocked by chloroquine treatment of the responder cells. These findings suggest a
sensing mechanism that is different from the recognition of canonicalMycoplasma-associated
lipoproteins by TLR2. Indeed, the activation of TLR2 by both theMycoplasma-derived lipopro-
tein MALP2 and the synthetic ligand Pam3CSK is not affected by chloroquine [27, 28]. We
confirm these data with the finding that IL-6 release from GM-CSF DCs in response toMyco-
plasma hyorhinis-infected B16 cell material was only partially dependent on functional TLR2
signaling. Furthermore, previous studies showed that the N-terminal lipoylated structures of
bacterial lipoproteins are vital for their recognition by TLR2 [7]. In line with this, enzymatic
degradation of the lipid moiety by lipase treatment but not protease treatment has been shown
to impair the pro-inflammatory properties of aMycoplasma-derived lipoprotein [23]. Thus,
our findings demonstrate that the culture supernatant fromMycoplasma hyorhinis-infected
B16 cells contain the TLR2-independent factors we describe alongside with canonical
TLR2-dependent ligands; presumably lipoproteins such as MALP-2. Interestingly, previous
studies in TLR2-deficient mice have already suggested that the innate immune system is able to
recognizeMycoplasma through mechanisms that are independent of TLR2, as these animals
did not show reduced IL-6 release in comparison to wild-type controls duringMycoplasma pul-
monis infection [10].
Due to our experimental setup, we cannot exclude transfer of infectiousMycoplasma hyor-
hinis to the immune cell cultures via the B16 supernatant. However, decontamination of the
B16 cell culture supernatants by filtration and/or UV irradiation had only a marginal effect on
their immunostimulatory capacity. These data demonstrate that this immune response is not
based on active infection. Whether the described immunstimulatory factors are of bacterial ori-
gin or constitute stress molecules released from B16 cells in response to chronic infection
remains to be determined.
Not only cDCs were activated by the factor released fromMycoplasma hyorhinis-infected
cell lines, but pDCs also similarly responded by producing large amounts of type-I IFNs. Plas-
macytoid DCs do not express significant levels of TLR2 but mainly endosomal TLR7 and
TLR9, which detect nucleic acids [29]. Both the dependency of cDC activation on MyD88 sig-
naling as well as the inhibition of pDC and cDC activation by chloroquine support the involve-
ment of TLR7 and/or TLR9 in this context. However, the protein factor released from
Mycoplasma hyorhinis-contaminated cell lines may not necessarily be a ligand for either TLR7
or TLR9, but could rather serve as a stabilizing, chaperone-like factor to nucleic acids. Indeed,
cell stress-associated factors such as the high-mobility group box (HMGB) proteins 1 and 2
have been shown to form stable complexes with nucleic acids that facilitate TLR ligation and
subsequent production of type-I IFNs and pro-inflammatory cytokines [30, 31]. Furthermore,
the antimicrobial peptide LL37 has been shown to bind both host DNA and extracellular RNA
released from dying cells [32, 33]. Within these complexes, nucleic acids are protected from
degradation and are transported into the endosome, where in pDCs they can trigger TLR-
dependent release of type-I IFNs. It will be of interest to investigate whether clinical
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Mycoplasma isolates are associated with similar ligands and whether their recognition plays a
role in pathology or protective immunity inMycoplasma infections.
In summary, we demonstrate thatMycoplasma hyorhinis-infected cells release factors that
are different in sensing, signaling and cytokine output from previously described TLR2 ligands,
indicating an involvement of either a novel ligand or non-canonical signaling pathway for the
detection ofMycoplasma hyorhinis contamination by bystander cells. These data demonstrate
a new mechanism by whichMycoplasma hyorhinis contamination can affect cell culture experi-
ments. Previous findings showed that chronicMycoplasma infection in a human monocytic
cell line can suppress its TLR function [11]. In contrast, we demonstrate here that primary
cells, which are shortly co-cultured with contaminated cells, produce pro-inflammatory cyto-
kines and type I interferon, probably through endosomal TLR activation. The precise nature of
the ligand remains to be elucidated. In conclusion,Mycoplasma contamination perturbs cell
culture experiments with immune cells on at least two levels: inhibition of TLR signaling in
chronic infection [11] and activation of innate immunity in short-term co-culture experiments.
The rigorous control ofMycoplasma infection is therefore essential also in primary immune
cells to avoid involuntary skewing of experimental results.
Supporting Information
S1 Fig. The immunostimulatory capacity of culture supernatant fromMycoplasma-con-
taminated cells is not specific to the murine B16 melanoma cell line. Freshly isolated murine
bone marrow cells were cultured in the presence of either cell lysates or the culture supernatant
of one of differentMycoplasma-infected murine tumor cell lines (B16 melanoma, CT26 colon
carcinoma or EL4 lymphoma). After 18 h, IL-6 levels in the bone marrow cell culture superna-
tant were measured by ELISA. Data give the mean + S.E.M. of triplicate samples and are repre-
sentative of at least three independent experiments. Asterisks indicate statistically significant
differences to the unstimulated control. SN, supernatant.
(TIF)
S2 Fig. Activation of innate immune cells by supernatant fromMycoplasma-infected cells
is inhibited by chloroquine treatment. (A) Bone marrow cells from wild-type mice were cul-
tured in the presence of diluted supernatant fromMycoplasma hyorhinis-infected B16 cells. In
some conditions, chloroquine was added to the cultures. After 18 h, IL-6 levels in the immune
culture supernatants were analyzed by ELISA. (B)Murine bone marrow cells or (C) GM-CSF
DCs were treated with chloroquine or control medium and were cultured in the presence of
different defined TLR ligands. After 18 h, IL-6 levels in the immune culture supernatants were
analyzed by ELISA. Data give the mean values of triplicate samples + S.E.M. that are represen-
tative of two independent experiments. Asterisks indicate statistically significant difference to
the appropriate non-inhibitor-treated conditions. ND, not determined.
(TIF)
S3 Fig. Irradiation and/or filtration efficiently decontaminate culture supernatants of
Mycoplasma-infected B16 cells.Non-infected B16 cells were cultured in the presence of super-
natant fromMycoplasma hyorhinis-contaminated B16 cells and were subsequently passaged
twice. Some of the infectious B16 culture supernatant was decontaminated by filtration and/or
UV irradiation before transmission to non-infected B16 cells. GM-CSF DCs were then cultured
in the presence of culture supernatant from either primarily infected B16 cells (black bars) or
B16 cells that had been co-cultured with infectious or decontaminated supernatant (red bars).
(A) After 18 h, levels of IL-6 in the DC culture were determined by ELISA. Data give the mean
values of triplicate samples + S.E.M. (B) The scheme gives an overview of the experimental
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design. SN, supernatant; prim., primary; second., secondary.
(TIF)
S4 Fig. Proteinase K treatment of B16 cell lysates results in strongly impaired upregulation
of IL-6 mRNA levels in bone marrow cells. Bone marrow cells were cultured in the presence
of cell lysates fromMycoplasma hyorhinis-infected B16 cells. Some B16 cell lysates were pre-
treated with proteinase K. 18 h later, IL-6 mRNA levels in the bone marrow cells were deter-
mined by quantitative real-time PCR. Data give the mean values of at least triplicate samples +
S.E.M. and are expressed as expression relative to actin mRNA.
(TIF)
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